Recognizing and managing on toxicities in cancer immunotherapy
Some research suggests berberine may support the release of GLP-1 by stimulating bitter receptors in the gut
The most expeditious approach is through injections
Impressive weight-loss results in clinical trials In 2015, the SCALE trial results demonstrated the effectiveness of once-daily injections of liraglutide (Saxenda)
These drawbacks are common to all injections, however, not just vitamin B12
3 , 4 , 5 Yet the increasing number of pharmacological alternatives to surgical interventions introduces distinct challenges, including high costs, limited long-term outcome data and potential side effects that can range from minimal to life-threatening, some of which are slow to emerge